Kevin D Judy
Overview
Explore the profile of Kevin D Judy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
832
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sarikonda A, Quraishi D, Self D, Sami A, Glener S, Lan M, et al.
J Neurooncol
. 2025 Mar;
PMID: 40063184
Background: Although many studies have examined outcomes after glioma surgery, few have explored the factors driving variation in the cost-effectiveness of surgical care. In this study, we integrate granular time-driven...
2.
Sarikonda A, Quraishi D, Glener S, Self D, Hafazalla K, Isch E, et al.
World Neurosurg
. 2025 Feb;
:123792.
PMID: 39956370
Introduction: Neurosurgeons lack precise insights into the true costs of transsphenoidal endoscopic surgery for sellar and suprasellar lesions (TESS), including pituitary adenomas, craniopharyngiomas, and apoplexy. To address this critical knowledge...
3.
Cappelli L, Uppendahl A, Gardner C, Khan M, Kayne A, Vemula S, et al.
J Clin Neurosci
. 2024 Jul;
127:110754.
PMID: 39068727
Purpose: Glioblastoma (GBM) is the most common primary brain cancer in adults with a very poor prognosis. Metabolic drivers of tumorigenesis are highly relevant within the central nervous system, where...
4.
Wan S, Rodrigues D, Kwiatkowski J, Khanna O, Judy K, Goldstein R, et al.
Cancers (Basel)
. 2023 Dec;
15(23).
PMID: 38067387
Previous work has reported the design of a novel thermobrachytherapy (TBT) balloon implant to deliver magnetic nanoparticle (MNP) hyperthermia and high-dose-rate (HDR) brachytherapy after brain tumor resection, thereby their synergistic...
5.
Lee I, Hanft S, Schulder M, Judy K, Wong E, Elder J, et al.
Future Oncol
. 2023 Dec;
20(10):579-591.
PMID: 38060340
Standard-of-care first-line therapy for patients with newly diagnosed glioblastoma (ndGBM) is maximal safe surgical resection, then concurrent radiotherapy and temozolomide, followed by maintenance temozolomide. IGV-001, the first product of the...
6.
Khanna O, Barsouk A, Momin A, Mahtabfar A, Andrews C, Hafazalla K, et al.
Acta Neurochir (Wien)
. 2023 Nov;
165(12):4175-4182.
PMID: 37987849
Purpose: Owing to their vicinity near the superior sagittal sinus, parasagittal and parafalcine meningiomas are challenging tumors to surgically resect. In this study, we investigate key factors that portend increased...
7.
Khanna O, Kazerooni A, Arif S, Mahtabfar A, Momin A, Andrews C, et al.
Neurosurg Focus
. 2023 Aug;
54(6):E17.
PMID: 37552657
Objective: The clinical behavior of meningiomas is not entirely captured by its designated WHO grade, therefore other factors must be elucidated that portend increased tumor aggressiveness and associated risk of...
8.
Poiset S, Reddy A, Tucker C, Kenyon L, Judy K, Shi W
J Med Case Rep
. 2023 Mar;
17(1):102.
PMID: 36935497
Background: Hemangioblastoma of the central nervous system is an uncommon benign neoplasm, with about 25% of cases in patients with von Hippel-Lindau disease. The incidence of metastasis is rare, particularly...
9.
Ali A, Lombardo J, Niazi M, Miller R, Alnahhas I, Martinez N, et al.
J Neurooncol
. 2022 Nov;
160(2):345-350.
PMID: 36355259
Materials And Methods: This is a single arm pilot study (clinicaltrials.gov Identifier: NCT03477110). Adult patients (age ≥ 18 years) with KPS ≥ 60 with newly diagnosed GBM were eligible. All...
10.
Barsouk A, Baldassari M, Khanna O, Andrews C, Ye D, Velagapudi L, et al.
J Clin Neurosci
. 2021 Oct;
93:82-87.
PMID: 34656266
Glioblastoma (GBM) with deep-supratentorial extension (DSE) involving the thalamus, basal ganglia and corpus collosum, poses significant challenges for clinical management. In this study, we present our outcomes in patients who...